NEW DELHI, 18 MAR: India on Friday prohibited the manufacturing, sale and distribution of two controversial drugs - Gatifloxacine and Tegaserod - for their side-effects.
Earlier Drug Technical Advisory Board's sub-committee on February 17 had decided to ban the drugs and had sent their proposal to the health ministry for final notification
.
Gatifloxacine is used as an antibiotic. But according to drug controller general of India, Dr Surinder Singh, "This drug is known to shoot up and also dip blood sugar levels."
Tegaserod is used in India for irritable bowel syndrome and chronic constipation. This drug, however,was banned globally after it showed a 10-fold increase in risk heart attacks and strokes.
Dr Singh said "Gatifloxacine and Tegaserod will be withdrawn from the Indian market in two weeks. Drug Technical Advisory Board has decided to ban their sale and use completely in the country."
No comments:
Post a Comment